340 related articles for article (PubMed ID: 25245204)
1. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
[TBL] [Abstract][Full Text] [Related]
2. Formation of osteoclast-like cells on HA and TCP ceramics.
Detsch R; Mayr H; Ziegler G
Acta Biomater; 2008 Jan; 4(1):139-48. PubMed ID: 17723325
[TBL] [Abstract][Full Text] [Related]
3. Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping.
Roy M; Bose S
J Biomed Mater Res A; 2012 Sep; 100(9):2450-61. PubMed ID: 22566212
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture.
Davison NL; ten Harkel B; Schoenmaker T; Luo X; Yuan H; Everts V; Barrère-de Groot F; de Bruijn JD
Biomaterials; 2014 Aug; 35(26):7441-51. PubMed ID: 24927681
[TBL] [Abstract][Full Text] [Related]
5. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
6. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone.
MacMillan AK; Lamberti FV; Moulton JN; Geilich BM; Webster TJ
Int J Nanomedicine; 2014; 9():5627-37. PubMed ID: 25506216
[TBL] [Abstract][Full Text] [Related]
7. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
10. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-kappaB ligand expression in osteoblasts.
Takami M; Mochizuki A; Yamada A; Tachi K; Zhao B; Miyamoto Y; Anada T; Honda Y; Inoue T; Nakamura M; Suzuki O; Kamijo R
Tissue Eng Part A; 2009 Dec; 15(12):3991-4000. PubMed ID: 19594360
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates.
Ciapetti G; Di Pompo G; Avnet S; Martini D; Diez-Escudero A; Montufar EB; Ginebra MP; Baldini N
Acta Biomater; 2017 Mar; 50():102-113. PubMed ID: 27940198
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
[TBL] [Abstract][Full Text] [Related]
14. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
[TBL] [Abstract][Full Text] [Related]
15. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
17. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
Ma X; Liu Y; Zhang Y; Yu X; Wang W; Zhao D
Biochem Biophys Res Commun; 2014 Mar; 445(2):282-8. PubMed ID: 24491533
[TBL] [Abstract][Full Text] [Related]
18. RANKL delivery from calcium phosphate containing PLGA microspheres.
Félix Lanao RP; Bosco R; Leeuwenburgh SC; Kersten-Niessen MJ; Wolke JG; van den Beucken JJ; Jansen JA
J Biomed Mater Res A; 2013 Nov; 101(11):3123-30. PubMed ID: 23529979
[TBL] [Abstract][Full Text] [Related]
19. Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation.
Zhang X; Aubin JE; Kim TH; Payne U; Chiu B; Inman RD
Infect Immun; 2004 Dec; 72(12):7183-9. PubMed ID: 15557643
[TBL] [Abstract][Full Text] [Related]
20. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios.
Yamada S; Heymann D; Bouler JM; Daculsi G
Biomaterials; 1997 Aug; 18(15):1037-41. PubMed ID: 9239465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
